The Long-Acting Ca2+-Channel Blocker Azelnidipine Prevents Left Ventricular Remodeling After Myocardial Infarction

The Long-Acting Ca2+-Channel Blocker Azelnidipine Prevents Left Ventricular Remodeling After Myocardial Infarction

Long-acting Ca2+-channel blockers have been reported to be effective in treating ischemic heart disease. However, their effects on cardiac remodeling after myocardial infarction (MI) are still unclear. We performed this study to examine the effect of azelnidipine on left ventricular (LV) remodeling,...

Full description

Bibliographic Details
Main Authors: Daisuke Nishiya, Soichiro Enomoto, Takashi Omura, Ryo Matsumoto, Takanori Kusuyama, Yasukatsu Izumi, Hiroshi Iwao, Kazuhide Takeuchi, Minoru Yoshiyama
Format: Article
Language:English
Published: Elsevier 2007-01-01
Series:Journal of Pharmacological Sciences
Online Access:http://www.sciencedirect.com/science/article/pii/S1347861319342938

Internet

http://www.sciencedirect.com/science/article/pii/S1347861319342938

Similar Items